5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the FDA since Dec. 22.

Advertisement

1. The Dermapace System is an external shock wave device that uses pulses of energy to stimulate wound healing.

2. Lynparza may now be used to treat breast cancer patients with metastasized tumors that carry a specific BRCA gene mutation.

  1. Cerebrotech Visor is a diagnostic device used to assess cerebral fluid volumes in patients undergoing neurological assessment.
  1. Xgeva may now be used to prevent bone fractures in patients with multiple myeloma.
  1. Oseltamivir phosphate capsules, a generic form of Roche’s Tamiflu, are used to treat uncomplicated influenza A and B.

More articles on supply chain:
Stanford Blood Center faces critical shortage of blood, notes the flu is keeping potential donors away
Demand surges for radiation antidote after Trump’s nuclear button tweet
FDA approves Tamiflu generic: 3 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.